EP1487414A4 - Antibiotische zusammensetzung - Google Patents

Antibiotische zusammensetzung

Info

Publication number
EP1487414A4
EP1487414A4 EP03714005A EP03714005A EP1487414A4 EP 1487414 A4 EP1487414 A4 EP 1487414A4 EP 03714005 A EP03714005 A EP 03714005A EP 03714005 A EP03714005 A EP 03714005A EP 1487414 A4 EP1487414 A4 EP 1487414A4
Authority
EP
European Patent Office
Prior art keywords
antibiotic composition
antibiotic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03714005A
Other languages
English (en)
French (fr)
Other versions
EP1487414A2 (de
Inventor
Edward M Rudnic
James D Isbister
Jr Donald J Treacy
Sandra E Wassink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MiddleBrook Pharmaceuticals Inc
Original Assignee
Advancis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/093,321 external-priority patent/US6610328B2/en
Priority claimed from US10/092,854 external-priority patent/US6627222B2/en
Priority claimed from US10/092,858 external-priority patent/US6632453B2/en
Priority claimed from US10/092,811 external-priority patent/US6623758B2/en
Priority claimed from US10/093,214 external-priority patent/US6638532B2/en
Application filed by Advancis Pharmaceutical Corp filed Critical Advancis Pharmaceutical Corp
Publication of EP1487414A2 publication Critical patent/EP1487414A2/de
Publication of EP1487414A4 publication Critical patent/EP1487414A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP03714005A 2002-03-07 2003-03-07 Antibiotische zusammensetzung Withdrawn EP1487414A4 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US10/093,321 US6610328B2 (en) 2000-02-24 2002-03-07 Amoxicillin-clarithromycin antibiotic composition
US10/092,854 US6627222B2 (en) 2000-02-24 2002-03-07 Amoxicillin-dicloxacillin antibiotic composition
US93214 2002-03-07
US92854 2002-03-07
US92811 2002-03-07
US10/092,858 US6632453B2 (en) 2000-02-24 2002-03-07 Ciprofoxacin-metronidazole antibiotic composition
US93321 2002-03-07
US92858 2002-03-07
US10/092,811 US6623758B2 (en) 2000-02-24 2002-03-07 Cephalosporin-metronidazole antibiotic composition
US10/093,214 US6638532B2 (en) 2000-02-24 2002-03-07 Tetracycline—doxycycline antibiotic composition
PCT/US2003/007118 WO2003075852A2 (en) 2002-03-07 2003-03-07 Antibiotic composition

Publications (2)

Publication Number Publication Date
EP1487414A2 EP1487414A2 (de) 2004-12-22
EP1487414A4 true EP1487414A4 (de) 2007-12-12

Family

ID=27808882

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03714005A Withdrawn EP1487414A4 (de) 2002-03-07 2003-03-07 Antibiotische zusammensetzung

Country Status (4)

Country Link
EP (1) EP1487414A4 (de)
JP (1) JP2005526059A (de)
CA (1) CA2478121A1 (de)
WO (1) WO2003075852A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
AU2006249100B2 (en) 2005-05-18 2012-01-19 Assistance Publique - Hospitaux De Paris Colonic delivery of adsorbents
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062195A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US20010046984A1 (en) * 2000-02-24 2001-11-29 Rudnic Edward M. Antibiotic composition with inhibitor
US20010048944A1 (en) * 2000-02-24 2001-12-06 Rudnic Edward M. Antibiotic product, use and formulation thereof
US20020013345A1 (en) * 1998-10-09 2002-01-31 Charles L. Berman Treatment of diseases of the eye characterized by the formation of metalloproteinase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
JPS63162619A (ja) * 1986-12-25 1988-07-06 Teisan Seiyaku Kk 遅溶性顆粒及びそれを用いた持続性複合顆粒
NL8800223A (nl) * 1987-04-21 1988-11-16 Philips Nv Systeem voor het registreren van een informatiesignaal, alsmede een registratiedrager en registratieinrichting voor toepassing in het systeem.
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
DE19718012C1 (de) * 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013345A1 (en) * 1998-10-09 2002-01-31 Charles L. Berman Treatment of diseases of the eye characterized by the formation of metalloproteinase
WO2001062195A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US20010046984A1 (en) * 2000-02-24 2001-11-29 Rudnic Edward M. Antibiotic composition with inhibitor
US20010048944A1 (en) * 2000-02-24 2001-12-06 Rudnic Edward M. Antibiotic product, use and formulation thereof

Also Published As

Publication number Publication date
WO2003075852A3 (en) 2004-07-15
AU2003218024B2 (en) 2008-09-11
JP2005526059A (ja) 2005-09-02
WO2003075852A2 (en) 2003-09-18
AU2003218024A1 (en) 2003-09-22
CA2478121A1 (en) 2003-09-18
EP1487414A2 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
CY20162200002T2 (el) Αντιιικοι παραγοντες
DE10393374D2 (de) Zusammensetzung
FR2862654B1 (fr) Composition amylacee filmogene
EP1537195A4 (de) Desinfizierende zusammensetzung
EP1491048A4 (de) Zusammengesetzte pufferung
BRPI0313075A2 (pt) composições de vidro
NO20044046L (no) Substituerte hydroksyetylaminer
EP1544279A4 (de) Schmiermittelzusammensetzung
EP1559433A4 (de) Stabilisierte zusammensetzung
DE60335716D1 (de) Beschleuniger-zusammensetzung
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
EP1482957A4 (de) Antibiotische konjugate
DK3006462T3 (da) Alfa-1-antitrypsin-sammensætning
DK1561472T3 (da) Faststofsammensætning
DE60304928D1 (de) Silica-gefüllte Elastomerenzusammensetzung
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DK1492934T3 (da) Dørenhed
EP1559771A4 (de) Schmiermittelzusammensetzung
SE0500163L (sv) Sammansättning
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE60304501D1 (de) Rostschutzzusammensetzung
EP1487414A4 (de) Antibiotische zusammensetzung
EP1561467A4 (de) Zusammensetzung zur wiederherstellung geschädigter haut
NO20044140D0 (no) New Composition
DE60335246D1 (de) Gewebsreparaturmatrix

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040930

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WASSINK, SANDRA, E.

Inventor name: TREACY, JR., DONALD, J.

Inventor name: ISBISTER, JAMES, D.

Inventor name: RUDNIC, EDWARD, M.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ADVANCIS PHARMACEUTICAL CORPORATION

A4 Supplementary search report drawn up and despatched

Effective date: 20071114

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MIDDLEBROOK PHARMACEUTICALS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091001